{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "4START San Antonio, San Antonio, TX, USA",
    "21Sarah Cannon Research Institute, Nashville, TN, USA",
    "3Washington University School of Medicine, St. Louis, MO, USA",
    "START Midwest, Grand Rapids, MI, USA",
    "2Department of Medical Oncology, Monash Health, Clayton, VIC, Australia",
    "5Austin Health, Heidelberg, VIC, Australia",
    "16Biolojic Design, Rehovot, Israel",
    "15Aulos Bioscience, Larkspur, CA, USA",
    "12Western Health, Sunshine Hospital, St Albans, VIC, Australia",
    "The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
    "Carolina BioOncology Institute, PLLC, Huntersville, NC, USA",
    "Minnesota Oncology and Hematology, Minneapolis, MN, USA",
    "Texas Oncology, Austin, TX, USA",
    "Biolojic Design Inc, Cambridge, MA, USA",
    "Aulos Bioscience, San Francisco, CA, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 18,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Drew Rasco"
    },
    {
      "affs": [
        1
      ],
      "name": "Meredith McKean"
    },
    {
      "affs": [
        2
      ],
      "name": "Ramaswamy Govindan"
    },
    {
      "affs": [
        3
      ],
      "name": "Nehal Lakhani"
    },
    {
      "affs": [
        4
      ],
      "name": "Sophia Frentzas"
    },
    {
      "affs": [
        5
      ],
      "name": "Andrew Weickhardt"
    },
    {
      "affs": [
        6
      ],
      "name": "Inbar Amit"
    },
    {
      "affs": [
        7
      ],
      "name": "Aron Knickerbocker"
    },
    {
      "affs": [
        6
      ],
      "name": "Yanay Ofran"
    },
    {
      "affs": [
        7
      ],
      "name": "Jenny Tang"
    },
    {
      "affs": [
        7
      ],
      "name": "Lori Richards"
    },
    {
      "affs": [
        8
      ],
      "name": "Catherine Oakman"
    },
    {
      "affs": [
        9
      ],
      "name": "George R Blumenschein"
    },
    {
      "affs": [
        10
      ],
      "name": "John D Powderly"
    },
    {
      "affs": [
        11
      ],
      "name": "Eric Lander"
    },
    {
      "affs": [
        12
      ],
      "name": "Jeffrey T Yorio"
    },
    {
      "affs": [
        13
      ],
      "name": "Timothy L Wyant"
    },
    {
      "affs": [
        14
      ],
      "name": "James R Vasselli"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/8vr66xjsrevgq.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0605",
  "fulltext_url": null,
  "id": "8vr66xjsrevgq",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0605",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7225307931",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A684.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-06",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/8vr66xjsrevgq.ris",
  "sources": [
    {
      "first_seen": "2026-11-07T14:21:05Z",
      "native_id": "2021ba8c9c0443d4b4462d76e0e758d1",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0605"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "605 Imneskibart, a human monoclonal antibody (mAb), + low-dose subcutaneous IL-2 + avelumab: phase 2 promising activity in CPI-refractory adenocarcinoma non-small cell lung cancer (NSCLC)",
  "title_text": "605 Imneskibart, a human monoclonal antibody (mAb), + low-dose subcutaneous IL-2 + avelumab: phase 2 promising activity in CPI-refractory adenocarcinoma non-small cell lung cancer (NSCLC)",
  "type": "peer-reviewed",
  "updated_at": "2026-11-08T14:20:32Z",
  "url": "https://research.draconitic.com/paper/8vr66xjsrevgq",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}